Applied DNA Sciences, Inc.
NASDAQ: APDN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James A. Hayward Sc.D.
- Employees
- 46
- Headquarters
- Stony Brook, United States
- IPO year
- 2003
- Market cap
- $7.3M
- Website
- https://www.adnas.com
Loading APDN…
Loading profile data…Frequently asked questions about APDN
What does Applied DNA Sciences, Inc. (APDN) do?
Applied DNA Sciences, Inc. specializes in devising and marketing sophisticated DNA-centric technological solutions across diverse sectors. Its activities encompass nucleic acid-based in vitro diagnostics and the preclinical development and production of nucleic acid-based pharmaceuticals. Furthermore, the company offers robust solutions for bols...
Where does APDN trade?
Applied DNA Sciences, Inc. (APDN) trades on the NASDAQ Capital Market.
What sector is APDN in?
Applied DNA Sciences, Inc. (APDN) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Applied DNA Sciences, Inc.?
James A. Hayward Sc.D. is the chief executive officer of Applied DNA Sciences, Inc. (APDN).
Where is Applied DNA Sciences, Inc. headquartered?
Applied DNA Sciences, Inc. is headquartered in United States.
Does APDN pay a dividend?
Applied DNA Sciences, Inc. (APDN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did APDN go public?
Applied DNA Sciences, Inc. (APDN) completed its initial public offering in 2003.